Research and Development

Showing 15 posts of 9607 posts found.

autolus_-_martin-pule

Promising new CAR-T therapy able to target T-cell lymphoma

November 15, 2017 Research and Development Autolus, CAR T, CAR-T, biotech, drugs, pharma, pharmaceutical

The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …

Psoriasis patients at greater risk of type 2 diabetes, study reveals

November 15, 2017 Research and Development diabetes, pharma, psoriasis, type 2 diabetes

Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …
kratom_leaf

FDA signals crackdown on controversial painkiller

November 15, 2017 Medical Communications, Research and Development biotech, drugs, kratom, pharma, pharmaceutical

Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to …
astrazeneca_building_white

AstraZeneca’s Fasenra scores US approval in severe asthma

November 15, 2017 Research and Development, Sales and Marketing AstraZeneca, Fasenra, MedImmune, asthma

AstraZeneca and MedImmune, the company’s biologics research and development division, have revealed the decision by the FDA to approve Fasenra …

WestRock’s Multi Packaging Solutions partners with Smartglyph for SmarterBarcodes

November 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

Multi Packaging Solutions, (MPS), a business of WestRock Company and a leader in value-added print and packaging solutions for the …
dia

Navigating the new Clinical Trial Regulation with DIA

November 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
novartis_side_building

Novartis targets specific patient population with strong Ilaris Phase 3 data

November 14, 2017 Manufacturing and Production, Research and Development Ilaris, Novartis, cardiovascular, heart attack, heart disease, pharma

Novartis has presented new Phase 3 data on its cardiovascular drug Ilaris (canakinumab) which demonstrate particular efficacy in a specific …

Hansa Medical mourns death of CEO

November 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hansa Medical, pharma

Swedish biopharma firm Hansa Medical broke tragic and unexpected news in November when it announced the death of its CEO …
1707_eu-agencies_relocations_website

EMA Headquarters: There’s no place like home

November 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, brexit, drugs, pharma, pharmaceutical

With the result of the Brexit referendum, the future of the EMA’s London headquarters was cast in doubt. Now, 19 …
novartis_window

Novartis touts longer-lasting AMD rival to Eylea

November 13, 2017 Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Novartis posted strong results for its wet age-related macular degeneration (AMD) drug, by showing superiority against Eylea in Phase 3 …
weight-2036971_960_720

UK rates of obesity increased by 92% over two decades

November 13, 2017 Research and Development, Sales and Marketing OECD, biotech, drugs, obesity, pharma, pharmaceutical

A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top ten

Friday again, and we bring you the most read articles on our site this week – one of which was …
shutterstock_187433765

Breast cancer recurrence can occur up to 20 years after treatment, report shows

November 10, 2017 Medical Communications, Research and Development Cancer, breast cancer, pharma, tamoxifen

New findings from the Early Breast Cancer Trialists’ Collaborative Group have demonstrated that oestrogen receptor-positive (ER-positive) breast cancer is able …
child-2916844_960_720

Sage scores good but not great P3 postpartum depression drug results

November 10, 2017 Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics share price soared 50% on the release that its two Phase 3 trials of brexanolone showed statistically significant …
The Gateway to Local Adoption Series

Latest content